产品名称
MISSION® esiRNA, targeting human SLC35F2
description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
CCTGGCCTGTTTGTTTGTTTGTTTAAAACATTTCTCCATCACTCATTCCAGGTCCCAGAGCAAACTCTCTCTGCTCTCGGAGCCTGTGACACTGGCTATGTGCTCCACAGTTTCAGTCCCAGGTCATACTCTCCAACAGTTTTCAGAGCTCCATATATATGTAGATGCCATCCTTTCTAAAAACTTCTCACGACCTCCTGGAATATTCCTATTGATCTCATTTTATTTAGCATCAGCTCAAGAAACTAAGTCTTAGTGCACAGTATCACAACAAAGAAAAAGCTTTGTTTTTATAACTGGTAAAAACAAGAAAAGATTCTCATCAAAATGAAAATATAAAATTAATCATTTCTCACCAAAGAGTATGCCTGGGAGCCTCCAGCTGTTAAAAGACAATGCTATTACTACTTCTTATCAAAAATCTGTAATGCCCTGTG
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
human ... SLC35F2(54733), SLC35F2(54733)
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Michael D Nyquist et al.
Molecular cancer research : MCR, 15(5), 521-531 (2017-05-04)
Androgen receptor (AR) signaling is fundamental to prostate cancer and is the dominant therapeutic target in metastatic disease. However, stringent androgen deprivation therapy regimens decrease quality of life and have been largely unsuccessful in curtailing mortality. Recent clinical and preclinical
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持